BOSTON, March 2, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has ...
Haemonetics HAE recently gained FDA’s 510(k) clearance for its next-generation Intelligent Control Software for Cell Saver Elite+ Autotransfusion System. The approval was followed by a full market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback